Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 3
1999 3
2000 1
2002 1
2003 4
2004 2
2005 2
2006 1
2007 3
2008 2
2009 2
2010 3
2017 1
2019 1
2020 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial.
De Man K, Van Laeken N, Schelfhout V, Fendler WP, Lambert B, Kersemans K, Piron S, Lumen N, Decaestecker K, Fonteyne V, Delrue L, De Vos F, Ost P. De Man K, et al. Among authors: schelfhout v. Eur Urol. 2022 Nov;82(5):501-509. doi: 10.1016/j.eururo.2022.05.010. Epub 2022 Jun 8. Eur Urol. 2022. PMID: 35690515 Clinical Trial.
Melatonin and painful gynecomastia.
De Bleecker JL, Lamont BH, Verstraete AG, Schelfhout VJ. De Bleecker JL, et al. Among authors: schelfhout vj. Neurology. 1999 Jul 22;53(2):435-6. doi: 10.1212/wnl.53.2.435. Neurology. 1999. PMID: 10430450 No abstract available.
Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management.
De Man K, Piron S, Van Laeken N, Delrue L, Fonteyne V, Lumen N, Van den Broeck B, Kersemans K, Ost P, Schelfhout V. De Man K, et al. Among authors: schelfhout v. Mol Imaging Biol. 2022 Oct;24(5):750-758. doi: 10.1007/s11307-022-01724-2. Epub 2022 Apr 11. Mol Imaging Biol. 2022. PMID: 35411446
Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study.
Debacker JM, Maris L, Cordier F, Creytens D, Deron P, Descamps B, D'Asseler Y, De Man K, Keereman V, Libbrecht S, Schelfhout V, Van de Vijver K, Vanhove C, Huvenne W. Debacker JM, et al. Among authors: schelfhout v. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2127-2139. doi: 10.1007/s00259-023-06153-z. Epub 2023 Mar 1. Eur J Nucl Med Mol Imaging. 2023. PMID: 36854863
Localization of BRCA1 protein at the cellular level.
De Potter CR, Coene ED, Schelfhout VR. De Potter CR, et al. Among authors: schelfhout vr. J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):423-9. doi: 10.1023/a:1018740216630. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819536 Review.
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR, François A, Altinay S, Arnould L, Balkenhol M, Broeckx G, Burguès O, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Hastir D, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchiò C, Martin Martinez MD, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban A, Sinke R, Stanciu-Pop CM, van Deurzen CHM, Van de Vijver KK, Van Rompuy AS, Vincent-Salomon A, Wen HY, Wong S, Bouzin C, Galant C. Van Bockstal MR, et al. Among authors: schelfhout v. Mod Pathol. 2021 Dec;34(12):2130-2140. doi: 10.1038/s41379-021-00865-z. Epub 2021 Jul 3. Mod Pathol. 2021. PMID: 34218258 Free PMC article.
33 results